A lot of waiting-room small talk between women now goes something like:
"How's the shot? Are you... regular?"
There's a reason it keeps coming up. About one in eight American adults has now taken a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound.
Most are happy with the weight side. Many are also dealing with a side effect their doctor barely mentioned - one that, for most, has gotten worse over time.
The medication is working. The gut piece is the part nobody prepared anyone for.
And the standard advice, like water, fiber, or walking more, isn't fixing it.
That's not because people are following it wrong. The playbook was written for a different problem.
The constipation we see on these medications isn't a malfunction - it's the same mechanism that's helping with the weight, just showing up downstream. The piece that gets missed in most appointments is that the usual advice for constipation wasn't written for this kind of slowdown. Patients end up cycling through fiber, water, and laxatives, and most of them are still uncomfortable a year in.